MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 80 filers reported holding MUSTANG BIO INC in Q3 2020. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 600 | -97.8% | 0.00% | – |
| Q1 2022 | $28,000 | -39.1% | 27,900 | 0.0% | 0.00% | – |
| Q4 2021 | $46,000 | -38.7% | 27,900 | -0.3% | 0.00% | – |
| Q3 2021 | $75,000 | -27.9% | 27,987 | -10.6% | 0.00% | – |
| Q2 2021 | $104,000 | +1.0% | 31,304 | +1.3% | 0.00% | – |
| Q1 2021 | $103,000 | +66.1% | 30,900 | +89.6% | 0.00% | – |
| Q4 2020 | $62,000 | +21.6% | 16,300 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -1.9% | 16,300 | 0.0% | 0.00% | – |
| Q2 2020 | $52,000 | +18.2% | 16,300 | 0.0% | 0.00% | – |
| Q1 2020 | $44,000 | -34.3% | 16,300 | 0.0% | 0.00% | – |
| Q4 2019 | $67,000 | +26.4% | 16,300 | 0.0% | 0.00% | – |
| Q3 2019 | $53,000 | -11.7% | 16,300 | 0.0% | 0.00% | – |
| Q2 2019 | $60,000 | +7.1% | 16,300 | 0.0% | 0.00% | – |
| Q1 2019 | $56,000 | +16.7% | 16,300 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -50.5% | 16,300 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | -23.0% | 16,300 | -10.9% | 0.00% | – |
| Q2 2018 | $126,000 | – | 18,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |